Schizoaffective Disorders (DBCOND0033299)

Identifiers

Synonyms
Schizo-Affective Disorder / Schizo Affective Disorder / Schizoaffective Disorder / Schizoaffective disorders / Schizoaffective disorder, unspecified / Schizoaffective disorder (disorder) / Schizophrenia schizoaffective / Schizoaffective schizophrenia (disorder) / Schizoaffective psychosis / Schizo-affective type schizophrenia

Associated Data

Indicated Drugs and Targets
DrugDescriptionTargets
Clozapine
An atypical or second-generation antipsychotic drug used in treatment-resistant schizophrenia and to decrease suicide risk in schizophrenic patients.
Paliperidone
An atypical antipsychotic used in the treatment of schizophrenia and other schizoaffective or delusional disorders.
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT02140788
Effects of Metformin and Fish Oil on Treatment With Clozapineother4terminated
NCT01003132
Assessing the Effectiveness of Acceptance and Commitment Therapy for Distress Following PsychosisNo drug interventionstreatmentNot Availablecompleted
NCT01720316
Neurobiology of a Mutation in Glycine Metabolism in Psychotic Disorderstreatment2completed
NCT01547026
Self-regulation Strategies to Improve Exercise Behavior Among Schizophrenic PatientsNo drug interventionstreatmentNot Availablecompleted
NCT02349880
A Shared Decision-making Training for Inpatients With SchizophreniaNo drug interventionshealth_services_researchNot Availablecompleted
NCT00463372
Study Investigating the Safety and Tolerability of Multiple Doses of PF-02545920 in Subjects With Schizophreniatreatment1completed
NCT05025605
Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disordertreatment1recruiting
NCT00515671
Illness Management and Recovery for Veterans With Severe Mental IllnessNo drug interventionstreatmentNot Availablecompleted
NCT01754532
Correlation Between Clinical Deterioration in Schizophrenic Patients and Hair Cortisol LevelsNo drug interventionsNot AvailableNot Availablecompleted
NCT02658357
Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH)-Risperidone When Risperidone is Administered From a Polyurethane ImplantNo drug interventionstreatment2completed
NCT04268303
Dexmedetomidine in the Treatment of Agitation Associated With SchizophreniaNo drug interventionstreatment3completed
NCT04907279
Aripiprazole Once-Monthly in Hospitalized Patients (INITIATE)No drug interventionsNot AvailableNot Availableunknown_status
NCT06093451
Evaluating Sublingual Dexmedetomidine For Moderate To Severe Agitation In Inpatients With Schizophrenia Or Bipolar Disordertreatment4recruiting
NCT03860597
Memantine Effects on Sensorimotor Gating and Neurocognition in Schizophreniasupportive_care4completed
NCT06134661
Accelerated rTMS for Psychomotor SlowingNo drug interventionstreatmentNot Availablerecruiting
NCT04113993
Bazedoxifene -Treatment for Women With Schizophreniatreatment4recruiting
NCT03751488
A Study to Determine Pharmacokinetic Characteristics of LY03010 Versus INVEGA SUSTENNA® in Schizophrenia Patientstreatment1completed
NCT06176456
Personalized Prospective Study Evaluation of the Efficacy and Safety of Noninvasive Neuromodulation of TMS in Subjects With CatatoniaNo drug interventionstreatmentNot Availablerecruiting
NCT05725785
Technology-Assisted Implementation of a Mobile Health Program for Serious Mental IllnessNo drug interventionssupportive_careNot Availablerecruiting
NCT03943537
Effects of Intranasal Insulin on Neuroimaging Markers and Cognition in Patients With Psychotic Disordersother2recruiting
NCT05538832
Remote State Representation in Early PsychosisNo drug interventionstreatment0recruiting
NCT03711500
D-serine Augmentation of Neuroplasticitytreatment1 / 2completed
NCT03221270
Targeting Auditory Hallucinations With Alternating Current StimulationNo drug interventionstreatmentNot Availablecompleted
NCT03881449
DIMES - DIgital MEdicine Study for Adults With Schizophrenia, Bipolar I Disorder, or Major Depression Currently Using Aripiprazoletreatment4unknown_status
NCT03208036
Restoration of Cognitive Function With TDCS and Training in Serious Mental IllnessNo drug interventionstreatmentNot Availablecompleted
NCT03774641
A Pilot Study of Prophylactic Management of Lamotrigine in Pregnant WomenNot AvailableNot Availablerecruiting
NCT03261817
A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic DisordersNo drug interventionssupportive_careNot Availableterminated
NCT04637724
Transcranial Weak Current Stimulation Treatments for Working Memory Dysfunction in SchizophreniaNo drug interventionstreatmentNot Availablecompleted
NCT04004416
Multi-modal Assessment of Gamma-aminobutyric Acid (GABA) Function in Psychosisbasic_science4recruiting
NCT06336616
Getting Out of the House: Using Behavioral Activation to Increase Community ParticipationNo drug interventionssupportive_careNot Availablerecruiting
NCT06474325
Feasibility and Acceptability of Mobile Mental Health App for SZ and SZANo drug interventionssupportive_careNot Availablenot_yet_recruiting
NCT05111548
Brain Stimulation and Cognitive Training - EfficacyNo drug interventionstreatmentNot Availablecompleted
NCT05899348
iTEST: Introspective Accuracy as a Novel Target for Functioning in Psychotic DisordersNo drug interventionstreatmentNot Availablerecruiting
NCT04068857
Repetitive Transcranial Magnetic Stimulation (rTMS) Self-Referential Processing (rTMS-SRP)No drug interventionstreatmentNot Availablewithdrawn
NCT04210557
Models of Auditory HallucinationNo drug interventionsbasic_scienceNot Availableterminated
NCT04856657
Targeting Individual Alpha Frequencies to Enhance Perceptual TimingNo drug interventionsNot AvailableNot Availablecompleted
NCT04323566
Rituximab Treatment for Psychosis and/or Obsessive Compulsive Disorder With Probable Immune System Involvementtreatment2enrolling_by_invitation
NCT05445466
Causal Lesion Network Guided Treatment of Bipolar Mania With Transcranial Electrical StimulationNo drug interventionstreatmentNot Availablerecruiting
NCT05109065
Peripheral Immune System in Individuals With SchizophreniaNo drug interventionsNot AvailableNot Availablerecruiting
NCT04054973
L-arginine Study for Persistent Symptoms of Schizophreniatreatment2withdrawn
NCT04005794
Virtual Reality Training for Social Skills in Schizophrenia - Comparison With Cognitive TrainingNo drug interventionsbasic_scienceNot Availablerecruiting
NCT05746494
The Efficacy of Neural Stimulation in Individuals With SchizophreniaNo drug interventionsbasic_scienceNot Availableactive_not_recruiting
NCT03346291
Examining Persistence in Smokers With SchizophreniaNo drug interventionstreatmentNot Availablecompleted
NCT06529029
Low Amplitude Pulse Seizure Therapy Versus Standard Ultra-Brief Right Unilateral Electroconvulsive TherapyNo drug interventionstreatment2 / 3recruiting
NCT03558529
Feasibility and Acceptability of a Smartphone App to Assess Early Warning Signs of Psychosis RelapseNo drug interventionsNot AvailableNot Availablecompleted
NCT04887792
Acetazolamide for Treatment Resistant Schizophreniatreatment1 / 2recruiting
NCT06041646
Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar Disordertreatment4completed
NCT05968638
Ketogenic Diet in People With SchizophreniaNo drug interventionstreatmentNot Availablerecruiting
NCT04327843
Reducing the Burden of Chronic Psychotic Disorders in Tanzania (CAPACITY)treatment3completed
NCT05046353
D-serine AudRem: R33 Phasetreatment1 / 2suspended
NCT05130853
Efficacy Study of a New Individualized Rehabilitation Programme for Social Cognition in Patients With SchizophreniaNo drug interventionstreatmentNot Availablecompleted
NCT05945277
Critical Time Intervention-Peer SupportNo drug interventionstreatmentNot Availablerecruiting
NCT05343598
Using Transcranial Magnetic Stimulation (TMS) to Understand Hallucinations in SchizophreniaNo drug interventionsbasic_scienceNot Availablerecruiting
NCT03059771
Mobile Enhancement of Motivation in SchizophreniaNo drug interventionstreatmentNot Availablecompleted
NCT04745507
Implementation, Efficacy and Costs of Inpatient Equivalent Home-Treatment in German Mental Health CareNo drug interventionsNot AvailableNot Availableunknown_status
NCT03183609
Confirmatory Efficacy Trial of a Gluten-Free Diet in a Subgroup of Persons With Schizophrenia Who Have High Levels of IgG Anti-Gliadin Antibodies (AGA IG)No drug interventionstreatmentNot Availablerecruiting
NCT04414215
Cognitive Training for Emotion Regulation in Psychotic DisordersNo drug interventionstreatmentNot Availablerecruiting
NCT05127837
CBTpro: Scaling up CBT for Psychosis Using Simulated Patients and Spoken Language TechnologiesNo drug interventionstreatmentNot Availableenrolling_by_invitation
NCT04325100
Intervention Targeting Motivational Negative SymptomsNo drug interventionstreatmentNot Availablecompleted
NCT04602741
Examining a Digital Health Approach for Advancing Schizophrenia Illness Self-management and Provider EngagementNo drug interventionstreatmentNot Availablecompleted
NCT06174116
Metabolic Effects of Adjunctive Lumateperone Treatment in Clozapine-Treated Patients With SchizophreniaNo drug interventionstreatment4recruiting
NCT05877716
EPI-MINN: Targeting Cognition and Motivation - NationalNo drug interventionstreatmentNot Availablerecruiting
NCT03868839
Telmisartan Pilot Study on Treatment Resistant SchizophreniaNo drug interventionsother2terminated
NCT03671525
Cognitive Effects of Nimodipine in Patients With SchizophreniaNo drug interventionsother0completed
NCT03192631
Financial Incentives to Improve Acceptance of Antipsychotic InjectionsNo drug interventionsotherNot Availableunknown_status
NCT03338673
Brain Stimulation and Cognitive TrainingNo drug interventionsotherNot Availablecompleted
NCT03794076
Cromoglicate Adjunctive Therapy for Outpatients With SchizophreniaNo drug interventionstreatment1 / 2recruiting
NCT04191876
Financial Incentives to Improve Medication AdherenceNo drug interventionshealth_services_researchNot Availablecompleted
NCT03129360
Levetiracetam in Early PsychosisNo drug interventionsother2completed
NCT06340789
Neurotransmitters in Treatment Resistant Schizophrenia Patients With add-on Sodium BenzoateNo drug interventionstreatment2not_yet_recruiting
NCT04099940
Virtual Reality Avatar Therapy for People Hearing VoicesNo drug interventionstreatmentNot Availablerecruiting
NCT04526067
In-person vs. Remote Wellness SupportNo drug interventionstreatmentNot Availablecompleted
NCT03648268
Using Transcranial Magnetic Stimulation (TMS) to Understand 'Negative' Symptoms of SchizophreniaNo drug interventionsbasic_scienceNot Availablecompleted
NCT06118268
iTBS to Enhance Social Cognition in People With PsychosisNo drug interventionstreatmentNot Availablerecruiting
NCT05973110
Examining the Efficacy of a Virtual Reality Cognitive Remediation Program for People Living With PsychosisNo drug interventionstreatmentNot Availablerecruiting
NCT05756855
Young Adults with Violent Behavior During Early PsychosisNo drug interventionshealth_services_researchNot Availablerecruiting
NCT01082588
Effects of Pravastatin on Cholesterol, Inflammation and Cognition in Schizophreniatreatment4completed
NCT00847600
Pregnenolone Augmentation in the Treatment of Patients With Recent-Onset SchizophreniaNo drug interventionstreatment4completed
NCT00457899
Rapid Versus Conventional Titration of Quetiapine in Schizophrenia/Schizoaffective Disordertreatment3terminated
NCT00392249
Supervised Treatment of Schizophrenia, a Randomized Controlled Trial.No drug interventionstreatment1 / 2unknown_status
NCT00645502
Bioequivalence Study Comparing 2 Formulations for 4 mg Risperidone Tablet.treatment1completed
NCT00526877
An Efficacy and Safety Study of Long-acting Risperidone in Participants With Schizophrenia or Schizoaffective Disorders Who Are Receiving Psychiatric Home Care Treatmenttreatment4completed
NCT00328978
Seroquel STACK Study in Schizophrenic or Schizoaffective Subjectstreatment3completed
NCT02307396
Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic PatientsNo drug interventionstreatment4completed
NCT00401973
Assessment of Safety and Efficacy of Therapy for the Prevention of Weight Gain Associated With OlanzapineNo drug interventionsprevention3completed
NCT00453804
Injectable Versus Oral Naltrexone Treatment of Alcohol Dependence In Serious Mental Illness (SMI)No drug interventionstreatment4completed
NCT00222495
A Comparative Study of New Medications for Psychosis in AdolescentsNo drug interventionstreatmentNot Availablecompleted
NCT01729650
Effectiveness of a Physical Activity and Diet Program in Patients With Psychotic Disorder (CapiCor)No drug interventionspreventionNot Availablecompleted
NCT01389908
A Follow up Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective DisorderNo drug interventionssupportive_careNot Availableunknown_status
NCT00440843
Zyprexa and Task Engagement in SchizophreniaNo drug interventionstreatment3withdrawn
NCT00208143
Seroquel Therapy for Substance Use Disorders Comorbid With SchizophreniaNo drug interventionstreatment4completed
NCT00861003
An Adherence Study of Antipsychotic Medication in Outpatients With Schizophrenia or Schizoaffective DisorderNo drug interventionsNot AvailableNot Availableunknown_status
NCT02986490
Magnesium Variations and Cardiometabolic Risk in Patients With Antipsychotic DrugsNo drug interventionspreventionNot Availableunknown_status
NCT01143090
A Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective DisorderNo drug interventionstreatment3completed
NCT00649064
A Study of the Effects of Ziprasidone for the Treatment of Schizophrenia or Schizoaffective Disorder in Patients Who Were Switched From Other Antipsychotic DrugsNo drug interventionstreatment4completed
NCT02415764
OnTrack>An Online Role-Playing Game: A Small Business Innovation Research (SBIR) GrantNo drug interventionshealth_services_research1completed
NCT02810964
Sulforaphane to Reduce Symptoms of SchizophreniaNo drug interventionstreatment2completed
NCT02775864
Comparative Effectiveness of Adaptive Treatment Strategies for SchizophreniaNo drug interventionsNot AvailableNot Availablecompleted
NCT00435721
Families Coping With Mental Illness ProgramNo drug interventionseducational_counseling_training1unknown_status
NCT00918021
Polypharmacy in Clozapine-resistant SchizophreniaNo drug interventionstreatment4completed
NCT00709202
Efficacy and Tolerability Study of Betahistine to Ameliorate Antipsychotic Associated Weight GainNo drug interventionstreatment2completed
NCT00061802
Efficacy and Safety of Two Atypical Antipsychotics vs. Placebo in Patients With an Acute Exacerbation of Either Schizophrenia or Schizoaffective DisorderNo drug interventionstreatment4completed
NCT00211302
Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (BMS)No drug interventionstreatmentNot Availableterminated
NCT00431184
Effects of Pentazocine Versus Lorazepam on Manic SymptomsNo drug interventionstreatment2completed
NCT00215579
Determining the Effects of Risperdal Consta in Patients With Psychotic Disorders and Incomplete AdherenceNo drug interventionstreatment4completed
NCT00141479
To Evaluate the Impact of Treatment Interruption on Re-initiation of BifeprunoxNo drug interventionstreatment2completed
NCT02398279
L-arginine add-on Therapy in Patients With SchizophreniaNo drug interventionstreatmentNot Availablecompleted
NCT02199743
Lurasidone Effects on Tissue Glutamate in SchizophreniaNo drug interventionstreatment4completed
NCT00361543
Selective Estrogen Receptor Modulators - A Potential Treatment for Psychotic Symptoms of SchizophreniaNo drug interventionstreatment4completed
NCT02901587
Study Investigating the Effect of Lu AF35700 on Cardiac Repolarization in Men and Women With Schizophrenia and Schizoaffective Disordertreatment1completed
NCT00051233
Treatment of Schizophrenia Through Internet-Based PsychoeducationNo drug interventionstreatment2completed
NCT01945333
Personalized and Scalable Cognitive Remediation ApproachesNo drug interventionstreatmentNot Availablecompleted
NCT00421954
Open-label Ziprasidone Study for Psychosis Treatment in Adolescentstreatment3completed
NCT03526354
Controlled Trial of Brexpiprazole For The Treatment of Co-occurring Schizophrenia and Substance Use Disordertreatment4completed
NCT03930251
Cognitive Remediation for Coordinated Specialty CareNo drug interventionstreatmentNot Availablecompleted
NCT00300651
Trial of Cognitive Behavioral Therapy for SchizophreniaNo drug interventionstreatment3unknown_status
NCT01609153
Comparison of Antipsychotic Combination Treatment of Olanzapine and Amisulpride to Monotherapytreatment4completed
NCT01028677
Oxytocin Treatment of SchizophreniatreatmentNot Availablecompleted
NCT00715377
Anticholinergic Burden in SchizophreniatreatmentNot Availableterminated
NCT01400477
Nicotinic Receptors and Schizophreniatreatment2completed
NCT00621777
A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia or Bipolar Disordertreatment4completed
NCT01321177
An Integrated Program for the Treatment of First Episode of PsychosisNo drug interventionstreatmentNot Availablecompleted
NCT02661347
Transcranial Direct Current Stimulation for Hallucinations in First-Episode SchizophreniatreatmentNot Availablewithdrawn
NCT00403247
Effect of High-Dose B-Complex Vitamins on the Symptoms of SchizophreniaNo drug interventionstreatmentNot Availablecompleted
NCT00641745
Lurasidone HCl - A Long Term Safety Phase 3 Study of Patients With Clinically Stable Schizophreniatreatment3completed
NCT00535145
Study to Measure the Safety of Paliperidone ER (Extended-release) in Patients With Liver Diseasetreatment4completed
NCT00818298
24-Hour Time Course of Striatal Dopamine D2 Receptor Occupancy of Ziprasidone: A PET StudyNo drug interventionstreatmentNot Availablecompleted
NCT04226898
Synbiotic Compound to Reduce Symptoms of Schizophreniatreatment2recruiting
NCT01866098
Naltrexone for Antipsychotic-Induced Weight GaintreatmentNot Availablecompleted
NCT00001198
Evaluating Genetic Risk Factors for Childhood-Onset SchizophreniaNo drug interventionsNot AvailableNot Availableterminated
NCT05859698
Study of the Effectiveness of Valbenazine on Patient- and Clinician-Reported Outcomes in Participants With Tardive Dyskinesiatreatment4active_not_recruiting
NCT00534898
Bexarotene and Fenretinide as Addition to Antipsychotic Treatment in Schizophrenia Patientstreatment3withdrawn
NCT01280305
Raloxifene in Treatment of Schizophrenia and Schizoaffective Disordertreatment3unknown_status
NCT06007105
SUCCEED Africa: Support, Comprehensive Care and Empowerment of People With Psychosocial DisabilitiesNo drug interventionssupportive_careNot Availablerecruiting
NCT05380583
Community Reinforcement and Family Training for Early Psychosis (CRAFT-EP) and Substance Use: A Pilot StudyNo drug interventionstreatmentNot Availablerecruiting
NCT00148083
Effects of Risperdal Consta on Ability to Benefit From Social Skills Training in Schizophreniatreatment3completed
NCT03617783
Prebiotic Treatment in People With Schizophrenia - Pilot StudyNo drug interventionsother4completed
NCT02360228
STimulation to Improve Auditory haLLucinationsNo drug interventionstreatmentNot Availablecompleted
NCT05712928
eMove - Dance/Movement Therapy StudyNo drug interventionstreatmentNot Availablecompleted
NCT00511628
Study on the Safety of Risperidone on Obese or Overweight Patients With SchizophreniaNot AvailableNot Availableterminated
NCT02075528
Early Prediction of Clinical Response in Patients With Schizophrenia Treated by Paliperidone ERtreatment4completed
NCT00728728
Pregnenolone for Cognitive and Negative Symptoms in Schizophreniatreatment2completed
NCT04418011
Neuromodulation of Social Cognitive Circuitry in People With Schizophrenia Spectrum DisordersNo drug interventionstreatmentNot Availablecompleted
NCT02124811
Minocycline Augmentation to Clozapinetreatment4completed
NCT00615511
Efficacy of Pregnenolone in Patients With SchizophreniaNo drug interventionstreatment2completed
NCT00975611
Study of Amantadine for Risperidone Consta or Paliperidone Treated Patients to Decrease Prolactin Elevationtreatment4terminated
NCT06251193
Optimizing CBSST With Executive Function Training for SchizophreniaNo drug interventionstreatmentNot Availablerecruiting
NCT00202293
Comparison of Combination Olanzapine+Lithium or Chlorpromazine+Lithium in Treatment of First Manic Episode With Psychotic Featurestreatment4completed
NCT00212771
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25520)(P05846)treatment3completed
NCT01731171
Probiotics to Prevent Relapse After Hospitalization for ManiaNo drug interventionstreatmentNot Availablecompleted
NCT01425671
Neural Oscillations as Genetic and Functional Biomarkers in Normal and Disease StatesNo drug interventionsNot AvailableNot Availablecompleted
NCT00480571
Safety and Tolerability of BL-1020 in Hospitalized Subjects With Chronic Schizophrenia or Schizo-Affective Disordertreatment2completed
NCT03757988
Targeting Physical Health in Schizophrenia: Physical Activity Can Enhance LifeNo drug interventionstreatmentNot Availablecompleted
NCT00507988
Complex Problem Solving Training in Schizophrenic PatientsNo drug interventionstreatmentNot Availablecompleted
NCT04038788
Add-on HD Hf-tRNS Over Bilateral DLPFC for Treating Patients With SchizophreniaNo drug interventionstreatmentNot Availablecompleted
NCT01888107
Maintenance of Efficacy With Risperidone Long Acting Injectable (R-LAI) in Patients With Schizophrenia or Schizoaffective Disordertreatment3completed
NCT00237809
D-Serine Treatment of Negative Symptoms and Cognitive Deficits in Schizophreniatreatment3completed
NCT01385709
The Influence of the Menstrual Cycle on Lithium and Sertraline Blood LevelsNo drug interventionsNot AvailableNot Availablecompleted
NCT01999309
Simvastatin Addition for Patients With Recent-onset Schizophreniatreatment3completed
NCT00453609
Injectable Naltrexone Treatment of Alcohol Dependence in Serious Mental Illness (SMI)treatment4completed
NCT02308956
Task Sharing for the Care of Severe Mental Disorders in a Low-income CountryNo drug interventionshealth_services_research3completed
NCT04783285
Effect of Individual Cognitive Stimulation at Home in Adults With Psychotic DisordersNo drug interventionstreatmentNot Availablecompleted
NCT00796185
As Study of the Pharmacokinetics of Paliperidone Extended-release and Risperidone Immediate-release Formulationstreatment1completed
NCT03571685
Sustainable Early Episode Clinic Study (SEEC)No drug interventionsotherNot Availablecompleted
NCT01392885
Brain Health and Exercise in SchizophreniaNo drug interventionsNot AvailableNot Availablerecruiting
NCT03708315
BXCL501 for Agitation in Schizophreniatreatment2recruiting
NCT03873337
Persistence Targeted Smoking Cessation in Serious Mental Illness (SMI)treatmentNot Availablecompleted
NCT02533232
Minocycline Augmentation of Clozapine for Treatment Resistant Schizophreniatreatment1unknown_status
NCT00644852
Medical Chart Review of Patients on Long-term Treatment With Long-acting Injectable RisperidoneNo drug interventionsNot AvailableNot Availablecompleted
NCT06221852
Ketogenic and Nutritional Interventions for First Episode Bipolar DisorderNo drug interventionstreatmentNot Availablerecruiting
NCT00287352
Study of Amantadine for Weight Stabilization During Olanzapine Treatmenttreatment1completed
NCT00686400
A German Multicenter Study on Toxoplasma Gondii in First-episode SchizophreniaNo drug interventionsNot AvailableNot Availableunknown_status
NCT02640300
Switching Antipsychotics: Abrupt Discontinuation Versus Overlaptreatment4completed
NCT03568500
A Trial to Explore Acceptance and Performance of Using a Digital Medicine System With Healthcare Professionals and Adults With Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis on an Oral Atypical Antipsychotichealth_services_research4completed
NCT01981759
D-Cycloserine Augmentation of Cognitive Behavioral Therapy for Delusionstreatment4completed
NCT01561859
Brain Imaging, Cognitive Enhancement and Early SchizophreniaNo drug interventionstreatmentNot Availablecompleted
NCT00960375
Smoking Cessation for Veterans With Severe and Persistent Mental IllnessNo drug interventionstreatment2 / 3completed
NCT00306475
Does The Addition Of Divalproex Sodium ER To An Atypical Antipsychotic Drug (APD) Improve Cognition And Psychopathology In Outpatients With Schizophrenia (SCH) Or Schizoaffective Disorder (SAD)?treatment4completed
NCT00517075
Treatment of Negative Symptoms of Schizophrenia With Transcranial Magnetic Stimulation (TMS)No drug interventionstreatment2terminated
NCT00138775
Israel Multicenter D-Serine Study (IMSER) for the Treatment of Schizophreniatreatment2unknown_status
NCT02267070
Enhancing Cognitive Training Through Exercise After a First Schizophrenia EpisodeNo drug interventionstreatmentNot Availablecompleted
NCT02782442
Cognitive Training Delivered Remotely to Individuals With Psychosis (ROAM)No drug interventionstreatmentNot Availablecompleted
NCT02636842
A Study of Aripiprazole Lauroxil in Subjects With Schizophrenia or Schizoaffective Disordertreatment1completed
NCT02417142
Exenatide Weekly Injections as an Adjunctive Treatment in Patients With Schizophreniatreatment4completed
NCT01169142
Study of Vitamin D in the Severely Mentally IllNo drug interventionstreatment4completed
NCT00018642
Quetiapine vs Haloperidol Decanoate for the Long Term Treatment of Schizophrenia and Schizoaffective DisordertreatmentNot Availablecompleted
NCT00538642
Improving Diabetes Risk Factors in Persons With Schizophrenia or Bipolar Disorder by Switching to ZiprasidonetreatmentNot Availablecompleted
NCT00108199
Generalization of Training in SchizophreniaNo drug interventionsNot AvailableNot Availablecompleted
NCT00470106
Improving Basic and Social Cognition in Veterans With SchizophreniaNo drug interventionstreatmentNot Availablecompleted
NCT00139906
Twice Daily Titration Study of Bifeprunox in Subjects With Schizophreniatreatment2completed
NCT00753506
Artemisinin to Reduce The Symptoms of SchizophreniaNo drug interventionstreatmentNot Availablecompleted
NCT02160249
RISE (Rehabilitation Intervention for People With Schizophrenia in Ethiopia)No drug interventionssupportive_careNot Availablecompleted
NCT06003036
Accelerated Transcranial Magnetic Stimulation for People With Schizophrenia Treated With ClozapineNo drug interventionsbasic_scienceNot Availablerecruiting
NCT00320736
Galantamine for Cognition in People With Schizophreniatreatment4completed
NCT04284813
Families With Substance Use and Psychosis: A Pilot StudyNo drug interventionstreatmentNot Availablecompleted
NCT02815813
Lifestyle Intervention for Young Adults With Serious Mental IllnessNo drug interventionstreatmentNot Availablecompleted
NCT03049813
Virtual Reality Job Interview Training in Severe Mental IllnessNo drug interventionsotherNot Availablecompleted
NCT01926613
Thinking Skills for Work in Severe Mental IllnessNo drug interventionstreatmentNot Availablecompleted
NCT00157313
Clinical Trial of Integrated Treatment Versus Standard Treatment in First Episode PsychosisNo drug interventionstreatmentNot Availableunknown_status
NCT00223418
Study Comparing Patients Taking Olanzapine and Patients Taking Aripiprazole on Learning of Vocational SkillsNot AvailableNot Availablecompleted
NCT04093518
Estradiol as add-on to Antipsychoticstreatment3unknown_status
NCT00495118
A Long-term Safety Study for Long-acting Injectable Risperidone in Schizophrenia or Schizoaffective Disorder Patients.treatment3completed
NCT00501618
Equivalence of Generic Clozapine to Orally Dissolving Clozapine in Schizophrenia or Schizoaffective Disorderbasic_science4completed
NCT01822418
Agomelatine Treatment of Depression in Schizophrenia (AGOPSYCH)treatment4completed
NCT01731119
Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescentstreatment2completed
NCT00269919
An Efficacy and Safety Study of Long-Term Risperidone Microspheres in Participants With Schizophreniatreatment4completed
NCT03370341
Stimulating the Brain to Improve Self-AwarenessNo drug interventionsbasic_scienceNot Availablecompleted
NCT02823041
Enhancing Cognitive Training Through Exercise Following a First Schizophrenia EpisodeNo drug interventionstreatmentNot Availablecompleted
NCT05779241
Study to Evaluate the Pharmacokinetics (PK) and Safety/Tolerability of Long-Acting Oral LYN-005treatment3completed
NCT01915017
Interventions to Improve Functional Outcome and Persistent Symptoms in SchizophreniaNo drug interventionstreatmentNot Availablecompleted
NCT05824117
Enhancing Educational and Vocational Recovery in Adolescents and Young Adults With Early Psychosis Through Supported Employment and Education.No drug interventionstreatmentNot Availablerecruiting
NCT02869334
Remediation of Auditory Recognition in Schizophrenia With tDCSNo drug interventionstreatmentNot Availablecompleted
NCT03079024
Minnesota Community-Based Cognitive Training in Early PsychosisNo drug interventionstreatmentNot Availablecompleted
NCT03495024
Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlatestreatment4recruiting
NCT01423916
Trial to Evaluate the Effects of OPC-34712 on QT/QTc in Subjects With Schizophrenia or Schizoaffective Disordertreatment1completed
NCT00261716
Motivational Interviewing to Improve Work Outcomes in SchizophreniaNo drug interventionstreatment3completed
NCT00885716
A Shared Decision Making Training for Inpatients With SchizophreniaNo drug interventionshealth_services_researchNot Availableunknown_status
NCT02131116
Integrated Metacognitive Therapy in First Episode PsychosisNo drug interventionstreatmentNot Availablecompleted
NCT04335916
Survey on Pre-ECT Evaluation and ECT ApplicationNo drug interventionsNot AvailableNot Availableunknown_status
NCT00237796
Functional Rehabilitation of Older Patients With SchizophreniaNo drug interventionstreatmentNot Availablecompleted
NCT01028196
Observational Study to Evaluate Bipolar Disorder Symptoms in Patients Presented With Schizophrenia or DepressionNo drug interventionsNot AvailableNot Availablecompleted
NCT06071858
Enhanced Coordinated Specialty Care for Early PsychosisNo drug interventionstreatmentNot Availablerecruiting
NCT05416658
Shared Decision Making for Antipsychotic MedicationsNo drug interventionshealth_services_researchNot Availablenot_yet_recruiting
NCT02593058
Positive Emotions Program for Schizophrenia (PEPS)No drug interventionstreatmentNot Availablecompleted
NCT01368458
Conversion to Antipsychotic MonotherapyNo drug interventionstreatmentNot Availableterminated
NCT00231335
Efficacy and Safety Study of Escitalopram Augmentation in Treatment Resistant Schizophreniatreatment4completed
NCT02090335
Health Promotion and Fitness for Younger and Older Adults With SMINo drug interventionspreventionNot Availablecompleted
NCT00057135
Improving Antipsychotic Adherence Among Patients With Serious Mental IllnessNo drug interventionstreatmentNot Availablecompleted
NCT01793935
Withania Somnifera: an Immunomodulator and Anti-inflammatory Agent for SchizophreniaNo drug interventionstreatmentNot Availablecompleted
NCT02237235
Effect of MMFS-202-302 on Cognitive Enhancement in SchizophreniaNo drug interventionstreatment2completed
NCT00690235
Demonstrate the Effects of Pramlintide on Weight Reduction in Schizophreniaother4completed
NCT05464563
Study by Electroencephalography of the Link Between the Lack of Self-compassion and the Disorder of Empathy in SchizophreniaNo drug interventionsotherNot Availablecompleted
NCT00001486
Genetic Study of SchizophreniaNo drug interventionsNot AvailableNot Availablerecruiting
NCT02197286
Targeted Vitamin D Treatment of Schizophrenia-Associated Hyperprolinemiatreatment2withdrawn
NCT00369239
Treatment With Risperidone Long Acting Injectable (RLAI) in an Early Phase of Psychosistreatment4completed
NCT01683539
Understanding How Cognitive Remediation WorksNo drug interventionstreatmentNot Availablecompleted
NCT02337439
Perceptual Deficits in SchizophreniaNo drug interventionstreatmentNot Availableunknown_status
NCT01786239
Omega-3 Dietary Supplements in SchizophreniatreatmentNot Availablecompleted
NCT02787122
Pilot-trial of Emotion-focused Cognitive Behavior Therapy for Patients With SchizophreniaNo drug interventionstreatmentNot Availablecompleted
NCT00224822
The Effects of Aripiprazole on Patients With Metabolic Syndrometreatment4completed
NCT00789022
Glutamatergic Amino Acids and Oxytocin Levels in the Plasma of Patients in First Psychotic Episode (FPE)- Before and After Neuroleptic TreatmentNo drug interventionsNot AvailableNot Availableunknown_status
NCT00538122
Changes in Heart Rhythms Associated With Antipsychotic Drug TreatmentNo drug interventionsNot AvailableNot Availablecompleted
NCT01875822
Open-label Study of Curcumin C-3 Complex in SchizophreniaNo drug interventionstreatment1 / 2completed
NCT01884025
Get Moving and Get Well - Pilot StudyNo drug interventionstreatmentNot Availablecompleted
NCT02224430
Prediction of Relapse in Schizophrenia/Schizoaffective Disorder With Smartphones and On-body SensorsNo drug interventionsNot AvailableNot Availablecompleted
NCT04414930
Pharmacologic Augmentation of Targeted Cognitive Training in SchizophreniaNo drug interventionstreatment2recruiting
NCT05567848
Accelerated TMS in PsychosisNo drug interventionstreatment1 / 2enrolling_by_invitation
NCT00575848
Study of the Effects of Glycine on Symptoms and Memory in Patients With SchizophreniaNo drug interventionsbasic_science1terminated
NCT05784948
Safety and Efficacy of Virtual Reality Mindfulness in Patients With PsychosisNo drug interventionspreventionNot Availablecompleted
NCT00946348
Cannabis and Schizophrenia: Self-Medication and Agonist Treatmentbasic_science1completed
NCT02566057
Prospective Pharmacogenetic Testing and Clinical Outcomes in Patients With Early-Phase PsychosisNo drug interventionstreatmentNot Availablecompleted
NCT00169026
Alcoholism and Schizophrenia: Effects of Clozapineother4terminated
NCT01521026
Cognitive Training for Patients With SchizophreniaNo drug interventionstreatmentNot Availablecompleted
NCT03559426
Research Into Antipsychotic Discontinuation and Reduction TrialNo drug interventionstreatment4completed
NCT00981526
Telmisartan as an Adjunctive Treatment for Metabolic Problems in Patients With Schizophreniatreatment4completed
NCT04916626
The OPUS YOUNG Trial. Early Intervention Versus Treatment as Usual for Adolescents With First-episode PsychosisNo drug interventionstreatmentNot Availablerecruiting
NCT00373126
The Effects of Nicotine Withdrawal on Reward Responsivity in Schizophreniatreatment4completed
NCT00400166
Recovery Guide Intervention for Recurrent Psychiatric HospitalizationNo drug interventionssupportive_careNot Availablecompleted
NCT00288366
Anticonvulsant Mood Stabilizers, Antipsychotic Drugs and the Insulin Resistance SyndrometreatmentNot Availablecompleted
NCT01093365
Effect of Varenicline on Cognitive Function in Cigarette Smokers With Schizophreniatreatment2completed
NCT03005574
Comparing Thinking Skills for Work (TSW)Home Practice Program With Traditional TSW ProgramNo drug interventionstreatmentNot Availablecompleted
NCT01855074
An Efficacy and Safety Study of Risperidone Long-Acting Microspheres in Participants With Schizophrenia, Schizophreniform or Schizoaffective Disorderstreatment4completed
NCT01788774
Pharmacokinetic, Safety, and Tolerability Study of Risperidone ISM® at Different Dose Strengthstreatment1completed
NCT02034474
Tocilizumab as Add-On Treatment For Residual Positive, Negative, and Cognitive Symptoms of Schizophreniatreatment4completed
NCT03621774
Mobile CBT for Negative SymptomsNo drug interventionstreatmentNot Availablecompleted
NCT04874974
Feasibility of a Novel Process-based Treatment for Patients With PsychosisNo drug interventionstreatmentNot Availablecompleted
NCT03043820
Raloxifene Augmentation in Patients With a Schizophrenia Spectrum Disordertreatment3completed
NCT03974620
Individual Placement and Support and/or Cognitive Remediation Therapy Added to TAU in Patients With Early SchizophreniaNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT00465920
Development and Pilot Evaluation of Modified Cognitive Behavioural Therapy for Adolescents With Early Onset PsychosisNo drug interventionstreatment2unknown_status
NCT01320982
Minocycline, Acetylsalicylic Acid or Pramipexole vs Placebo in Patients With Schizophrenia or Schizoaffective Disordertreatment3unknown_status
NCT00192582
AIMHI NT Relapse Prevention TrialNo drug interventionsNot AvailableNot Availableunknown_status
NCT01828931
Lifestyle Intervention for Diabetes and Weight Management in PsychosisNo drug interventionstreatmentNot Availablecompleted
NCT01309373
An Epidemiological Study to Assess the Psychosocial and Symptomatic Remission and Community Integration Status in Patients With SchizophreniaNo drug interventionsNot AvailableNot Availablecompleted
NCT00314327
Optimizing Response in Psychosis Studytreatment4terminated
NCT03880227
Improving Visual Attention in SchizophreniaNo drug interventionsbasic_scienceNot Availablecompleted
NCT01913327
Antipsychotic Effects on Brain Function in Schizophreniatreatment4terminated
NCT03576976
Improving Accessibility and Personalization of CR for SchizophreniaNo drug interventionstreatmentNot Availablecompleted
NCT00100776
Efficacy of High Dose Olanzapine for the Treatment of Schizophrenia and Schizoaffective Disordertreatment4completed
NCT00430560
Work Activity Augmented by Cognitive Rehabilitation for SchizophreniaNo drug interventionstreatment2 / 3completed
NCT00222794
A Clinical Trial to Examine Effects of Atomoxetine in the Treatment of Negative Symptoms in Patients With Schizophreniatreatment4completed
NCT04545294
Theta tACS During Working Memory Training: A Pilot Study of the Effects on Negative Symptoms of SchizophreniaNo drug interventionstreatmentNot Availablecompleted
NCT05664594
State Representation in Early Psychosis - Project 4No drug interventionsbasic_scienceNot Availablerecruiting
NCT00179062
Effects of Risperidone and Olanzapine on Patients With Schizophrenia, Schizoaffective Disorder, Major Depression or Bipolar DisordertreatmentNot Availablecompleted
NCT00177580
Improving Symptoms of Schizophrenia and Schizoaffective Disorder by Supplementing Medications With Pravastatintreatment4completed
NCT02334280
Evaluation of A Statewide Program to Prevent Early Mortality and to Promote Fitness in Persons With SMINo drug interventionshealth_services_researchNot Availablecompleted
NCT04011280
Novel Pharmacotherapy Approaches in Smokers With Serious Mental Illnesstreatment4completed
NCT00211380
Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (SFBRI)treatmentNot Availableterminated
NCT02131129
rTMS in First Episode PsychosisNo drug interventionstreatmentNot Availablecompleted
NCT00650429
A Study of the Efficacy and Safety of Ziprasidone for the Treatment of Acute Exacerbation of Schizophrenia or Schizoaffective Disordertreatment4completed
NCT02642029
Targeting Cerebellum to Treat Psychosis: a Transcranial Magnetic Stimulation (TMS) StudyNo drug interventionsbasic_scienceNot Availablecompleted
NCT01542229
PTSD (PostTraumatic Stress Disorder) Services for Veterans With SMI (Severe Mental Illness)No drug interventionshealth_services_researchNot Availablecompleted
NCT00681629
Schizophrenic Patients in Integrated Caretreatment4terminated
NCT03314129
Remediation of Visual Perceptual Impairments in People With SchizophreniaNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT00645229
A Study of the Efficacy and Safety of Ziprasidone in Patients With Acute Exacerbation of Schizophrenia or Schizoaffective Disordertreatment3terminated
NCT02326389
Exercise and Cognitive TrainingNo drug interventionstreatmentNot Availablecompleted
NCT00325689
Aripiprazole Used as Dual Therapy in the Treatement of Patients With Chronic Stable Schizophrenia or Schizoaffective Disorder.treatment4completed
NCT01398189
F-18 Altanserin PET Study of Patients Receiving Clozapinebasic_scienceNot Availableunknown_status
NCT02069392
Nicotinic Enhancement of Cognitive Remediation Training in SchizophreniatreatmentNot Availablecompleted
NCT02796144
MEtformin and Lorcaserin for WeighT Loss in Schizophreniatreatment4terminated
NCT00645944
Randomized, Controlled, Double Blind Trial of Eszopiclone for Insomnia Associated With SchizophreniatreatmentNot Availablecompleted
NCT00206544
Anti-Estrogens - A Potential Treatment for Bipolar Affective Disorder in Women?treatment2completed
NCT00499044
A Comparison of Two Cognitive Batteries in People With SchizophreniaNo drug interventionsNot AvailableNot Availablecompleted
NCT00791440
Recovery From Psychosis in Schizophrenia - The Impact of Cognitive-Behavioral TherapyNo drug interventionstreatmentNot Availablecompleted
NCT04068467
Evaluation of mHealth for Serious Mental IllnessNo drug interventionssupportive_careNot Availablecompleted
NCT00545467
Evaluation of the Strategies of Switching Schizophrenia Patients to Aripiprazole From Other Antipsychotic Agentstreatment4completed
NCT01546467
Cognitive Remediation in Early Phase PsychosisNo drug interventionstreatmentNot Availableunknown_status
NCT02159001
Electroconvulsive Therapy in Clozapine-resistant SchizophreniaNo drug interventionstreatmentNot Availableunknown_status
NCT00034801
Olanzapine Versus Active Comparator in the Treatment of Depression in Patients With Schizophreniatreatment4completed
NCT00595504
Ramelteon as an Adjunct Therapy in Non-Diabetic Patients With Schizophreniatreatment4completed
NCT01729572
Measuring the Effect of Remote Monitoring of Treatment Adherence on the Risk of Re-admission of Ambulatory Schizophrenic PatientsNo drug interventionstreatmentNot Availableunknown_status
NCT04986072
Sodium Nitroprusside in Early Course Schizophreniatreatment2terminated
NCT04173572
Targeting Physical Health in Schizophrenia: Physical Activity Can Enhance Life Randomized Control TrialNo drug interventionstreatmentNot Availablecompleted
NCT01136772
A Comparison of Long-acting Injectable Medications for Schizophreniatreatment4completed
NCT00373672
Effects of Armodafinil on Cognition for Patients With Schizophrenia or Schizoaffective Disordertreatment4completed
NCT01570972
Mediators and Moderators of Treatment Outcome in Recent-Onset PsychosisNo drug interventionstreatmentNot Availablecompleted
NCT02573168
Pharmacogenomic Decision Support With GeneSight Psychotropic to Guide the Treatment With AntipsychoticsNo drug interventionstreatmentNot Availablecompleted
NCT01764568
Contrasting Group Therapy Methods for PsychosisNo drug interventionstreatmentNot Availableterminated
NCT03197168
Psychosocial Intervention to Reduce Self-stigma and Improve Quality of Life Among People With Mental Illness in ChileNo drug interventionshealth_services_researchNot Availablecompleted
NCT00208169
Abilify Therapy for Reducing Comorbid Substance Abusetreatment4completed
NCT01029769
Efficacy of an Early Antipsychotic Switch in Case of Poor Initial Response to the Treatment of SchizophreniatreatmentNot Availablecompleted
NCT00419146
Treatment of Schizophrenia With an Omega-3 Fatty Acid (EPA) and Antioxidantstreatment2 / 3completed
NCT00090012
Comparison of Continuing Olanzapine to Switching to Quetiapine in Overweight or Obese Patients With Schizophrenia and Schizoaffective Disordertreatment4completed
NCT01182012
Reduction of Cardiovascular Risk in Severe Mental IllnessNo drug interventionsprevention4unknown_status
NCT00253110
A Comparison of Risperidone With Haloperidol in Patients With Schizophrenia and Schizoaffective Disordertreatment4completed
NCT01269710
Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT00167310
Decreasing Risk of Coronary Artery Disease in Schizophrenia by Omega-3 Fatty Acid Supplementationtreatment2completed
NCT00646581
Effect of Single Dose Intranasal Insulin On Cognitive Functiontreatment4completed
NCT01001481
Schizophrenia Treatment Adherence Investigation (STAI)No drug interventionsNot AvailableNot Availablecompleted
NCT00942981
Functional Relevance of Dopamine Receptors in Healthy Controls and Patients With Schizophrenia: Characterization Through [11C]NNC-112 and [18F]Fallypride Positron Emission TomographyNo drug interventionsNot AvailableNot Availablerecruiting
NCT01474395
N-methyl-D-aspartic Acid (NMDA) and Cognitive Remediation in Schizophreniatreatment2unknown_status
NCT01248195
Optimization of Treatment and Management of Schizophrenia in Europetreatment4completed
NCT00500695
Enhancing Motivation To Quit Smoking In Smokers With Serious Mental IllnessNo drug interventionstreatment1completed
NCT01450514
POC Study of Pipamperone Added to Stable Treatment With RIS or PAL in Chronic Schizophreniatreatment2completed
NCT01769014
Adherence and Quality of Life in People With Schizophrenia and Schizoaffective DisorderNo drug interventionsNot AvailableNot Availableunknown_status
NCT01555814
Optimization of Treatment and Management of Schizophrenia in Europe (OPTIMISE): Substudy Site CopenhagendiagnosticNot Availablecompleted
NCT00132314
Long-Acting Injectable Risperidone in the Treatment of Schizophreniatreatment3completed
NCT05746455
Motivation Skills Training for SchizophreniaNo drug interventionstreatmentNot Availablecompleted
NCT04013555
The Effects of Kynurenine Aminotransferase Inhibition in People With Schizophreniaother1 / 2recruiting
NCT00304655
Acute Psychosis Treatment in the Long Term, Unitary Group Study (APLUS)treatment4completed
NCT00929955
Role of Anti-Inflammatory Agents in Patients With Schizophreniatreatment1completed
NCT00716755
Minimizing Doses of Antipsychotic Medication in Older Patients With Schizophrenia.treatmentNot Availablecompleted
NCT01880255
rTMS for Working Memory Deficits in SchizophreniaNo drug interventionstreatmentNot Availablecompleted
NCT03921450
Overcoming Psychomotor Slowing in Psychosis (OCoPS-P)No drug interventionstreatmentNot Availablecompleted
NCT01658150
Evaluating Isradipine for Cognitive Enhancement in Schizophrenia and Schizoaffective Disordersupportive_careNot Availablecompleted
NCT04298450
ED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis InterventionNo drug interventionshealth_services_researchNot Availablerecruiting
NCT01043250
Effects of Atypical Antipsychotics on Appetite and Eating Behavior of Schizophrenia PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT00176423
Efficacy Study of Galantamine for Cognitive Impairments in Schizophreniatreatment4completed
NCT02149823
Examining Dose-Related Effects of Oxytocin on Social Cognition Across Populationsbasic_science1terminated
NCT00320723
Nicotine Replacement Therapy for Smoking Cessation in Schizophreniatreatment4completed
NCT04123223
Comparing Cognitive Remediation Approaches for SchizophreniaNo drug interventionstreatmentNot Availableunknown_status
NCT00514423
How Can Rehospitalisations of Patients With Schizophrenia be Avoided? A Comparison Between Different Compliance ProgramsNo drug interventionspreventionNot Availablecompleted
NCT00177008
Aripiprazole for the Treatment of Schizophrenia With Co-Morbid Social Anxietytreatment4completed
NCT03896438
Maximizing the Impact of Neuroplasticity Using Transcranial Electrical Stimulation Study 2No drug interventionstreatmentNot Availableactive_not_recruiting
NCT00423943
Modafinil for Treatment of Cognitive Dysfunction in Schizophreniatreatment4completed
NCT02921243
Schizophrenia and the Gut MicrobiomeNo drug interventionsNot AvailableNot Availablecompleted
NCT00316303
Effectiveness of the Screen, Test, Immunize, Reduce Risk, and Refer (STIRR) Intervention for People With Both a Mental and Substance Abuse Disordertreatment2completed
NCT00727103
Varenicline Treatment in Alcohol and Nicotine Dependent Patients With Schizophreniatreatment4completed
NCT05208190
Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trialtreatment4recruiting
NCT05273164
State Representation in Early PsychosisNo drug interventionsbasic_scienceNot Availablerecruiting
NCT00672464
Cardio Risk of Acute Schizophrenia Olanzapine Dukeprevention4withdrawn
NCT03316664
Assessment of Efficacy of a Psychological Therapy in Inpatients With a Schizophrenic PsychosisNo drug interventionstreatmentNot Availablecompleted
NCT00469664
Guanfacine Adjunctive Treatment to Atypical Antipsychotics for Cognitive Dysfunction in Schizophreniatreatment4unknown_status
NCT06107764
Cerebellar Modulation of Cognition in PsychosisNo drug interventionsotherNot Availablerecruiting
NCT01101464
A Trial to Determine Whether Two Differing Strength Tablets (3 x 5 mg Versus 1 x 15 mg) of Sublingually Org 5222 (Asenapine) Are Safe and Equal in Subjects With Schizophrenia or Schizoaffective Disorder (P05937)basic_science2completed
NCT02188121
Fixed Dose Intervention Trial of New England Enhancing Survival in SMI Patientstreatment4completed
NCT04554121
Efficacy of Personalizing Cognitive Remediation for Schizophrenia by Targeting Impairments in Early Auditory ProcessingNo drug interventionstreatmentNot Availableenrolling_by_invitation
NCT02639702
Switching From Twice-Daily to Once-Daily Clozapine Dosing in Schizophreniatreatment4recruiting
NCT00206102
A Study of the Cataractogenic Potential of Seroquel and Risperdal in the Treatment of Participants With Schizophrenia or Schizoaffective Disordertreatment4completed
NCT06286202
Integrative Neuro-social Cognitive Strategy Programme for Instilling REcovery (INSPIRE) a Community-Based Cognitive Remediation TrialNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT00303602
Comparing the Effect of Under the Tongue Olanzapine Versus Swallowed Olanzapine on Body Mass Index (A Ratio of Weight to Height)treatment4completed
NCT01975584
Neuroendocrine and Immune Response to Stress in SchizophreniaNo drug interventionsotherNot Availablecompleted
NCT00212784
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)treatment3completed
NCT01425684
Brain Circuits in Schizophrenia and SmokingNo drug interventionsNot AvailableNot Availablecompleted
NCT00283179
Aripiprazole in the Treatment of Acutely Relapsed Patients With Schizophreniatreatment3completed
NCT03288779
Theta Burst Stimulation for SchizophreniaNo drug interventionstreatmentNot Availablecompleted
NCT02055287
Pharmacokinetic and Safety Study of LY03004 in Stable Patients With Schizophrenia or Schizoaffective DisorderNo drug interventionstreatment1completed
NCT06182787
Development of a Model for Digital Monitoring of the Mental State of the Hospitalized PatientNo drug interventionsNot AvailableNot Availablerecruiting
NCT00397033
Evaluation of Effectiveness and Safety of Paliperidone Extended Release in Patients With Schizoaffective Disorder.treatment3completed
NCT00817154
Individually Based Psychosocial Rehabilitation for Older People With Serious Mental Illness (SMI)No drug interventionshealth_services_research1completed
NCT01004354
Vitamin D Supplementation in Psychiatric IllnessestreatmentNot Availablecompleted
NCT03388554
The Effects of tDCS on Auditory Hallucination, Insight, Neurocognitive Function and HRV in Patients With SchizophreniaNo drug interventionstreatmentNot Availablecompleted
NCT02504151
Cannabidiol Treatment in Patients With Early Psychosistreatment2completed
NCT00836251
Effects of Antipsychotic Medications on Energy Intake and ExpenditureNo drug interventionsNot AvailableNot Availablecompleted
NCT01941251
Navigated αTMS in Treatment-resistant SchizophreniaNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT04673851
Horyzons: Implementation in Clinical PracticeNo drug interventionstreatmentNot Availablecompleted
NCT06423651
Benefits of Combining MCT With CR in the Recovery of Patients With Psychotic Spectrum DisordersNo drug interventionstreatmentNot Availablerecruiting
NCT00936351
Mindfulness Meditation as a Rehabilitation Strategy for Persons With SchizophreniaNo drug interventionstreatmentNot Availablecompleted
NCT01198353
Effectiveness of Ziprasidone for Patients With Schizophreniatreatment4completed
NCT00288353
Estimating and Reducing the Cardiovascular Risk of Patients With Schizophrenia Drugs From Lipid Measures and Ischemic Electrocardiographic Changestreatment3terminated
NCT00995553
Remediation of Working Memory in SchizophreniaNo drug interventionstreatmentNot Availablecompleted
NCT03050853
The Appeal and Impact of E-cigarettes in Smokers With SMINo drug interventionsotherNot Availablecompleted
NCT01193153
A Study to Evaluate the Efficacy of Paliperidone Palmitate in the Prevention of Relapse of the Symptoms of Schizoaffective Disorderprevention3completed
NCT00701753
A Pharmacogenetic Investigation of Antipsychotics in Schizophrenia and Schizophrenia-Like PsychosesNo drug interventionsNot AvailableNot Availableterminated
NCT02034253
Glutamate, Brain Connectivity and Duration of Untreated PsychosisNot AvailableNot Availablecompleted
NCT00407277
Neural Inhibition as a Mechanism of Nicotine Dependence Among Persons With Schizophreniabasic_scienceNot Availablecompleted
NCT01143077
A Study Evaluating Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agentstreatment3completed
NCT00797277
Intramuscular (IM) Olanzapine Versus IM Haloperidol Plus Lorazepam for Acute Agitation in Schizophreniatreatment3completed
NCT01292577
Adapted Cognitive/Affective Remediation for Cannabis Misuse in SchizophreniaNo drug interventionstreatment1 / 2completed
NCT00177177
L-carnosine for SchizophreniatreatmentNot Availablecompleted
NCT00297947
High Dose of Quetiapine in Treating Subjects With Treatment Refractory Schizophrenia or Schizoaffective Disordertreatment2 / 3completed
NCT02085447
A Concierge Model of CAE Plus LAI in Individuals With Schizophrenia at Risk for Treatment Non-adherence and HomelessnessNo drug interventionssupportive_careNot Availablecompleted
NCT00825045
Dopamine D2 and D3 Receptor Occupancy and Clinical Response in Older Patients With SchizophreniatreatmentNot Availableunknown_status
NCT00312598
Body Mass Index (BMI) and Metabolic Changes Following Switch to Aripiprazole From Olanzapine, Risperidone and QuetiapineNot AvailableNot Availablecompleted
NCT01092598
Factors Association With Poor Physical Function in Older Adults With SchizophreniaNo drug interventionsNot AvailableNot Availablecompleted
NCT00558298
A Long Term Study of Safety for Long Acting Injectable Risperidone in Patients With Schizophrenia or Schizoaffective Disorder.treatment3completed
NCT02386605
Motivational Negative Symptoms in Schizophrenia: Intervention and BiomarkersNo drug interventionstreatmentNot Availablecompleted
NCT02930005
Pentosan Polysulfate Sodium and Meclofenamic Acid as Treatments in Patients With Psychotic Disorderstreatment2completed
NCT01065597
Nonconvulsive Electrotherapy: a Proof-of-concept TrialNo drug interventionstreatment1completed
NCT01794897
Valacyclovir Augmentation for Cognitive and Functional Remediation in Schizophreniabasic_science4completed
NCT05805397
Effectiveness of Motivation Skills Training (MST)No drug interventionstreatmentNot Availablerecruiting
NCT00320697
Smoking Relapse Prevention in Schizophreniatreatment4completed
NCT05670197
Service User and Staff Views on Digital Remote Monitoring for PsychosisNo drug interventionsNot AvailableNot Availablerecruiting
NCT04857983
Memantine Augmentation of Targeted Cognitive Training in Schizophreniatreatment2 / 3recruiting
NCT01215383
The Antiatherogenic Properties of HDL in Psychiatric Patients With and Without Antipsychotic TherapyNo drug interventionsNot AvailableNot Availableunknown_status
NCT00378183
A Study Comparing Three Strategies to Switch Patients With Schizophrenia or Schizoaffective Disorder to Risperidone After Unsuccessful Treatment With Olanzapine.treatment4completed
NCT03037983
Improving Neurocognitive Deficits and Function in Schizophrenia With Transcranial Magnetic StimulationNo drug interventionssupportive_careNot Availablecompleted
NCT00523783
Seroquel Long-Term NIS for Schizophrenia PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT05890183
Improving Cognition Through Telehealth Aerobic Exercise and Cognitive Training After a First Schizophrenia EpisodeNo drug interventionstreatmentNot Availablerecruiting
NCT00350883
Cognitive Therapy for Negative Symptoms and FunctioningNo drug interventionstreatment2completed
NCT00465283
Donepezil Double Blind Trial for ECT Memory Disfunctiontreatment4unknown_status
NCT01481883
Selective Estrogen Receptor Modulators (SERMs) - A Potential Treatment for Psychotic Symptoms of Schizophrenia in Men?treatment4completed
NCT00391261
An Open-label Trial of Metformin for Weight Control of Pediatric Patients on Antipsychotic Medications.treatment4completed
NCT00036361
Broad Effectiveness: Study With Aripiprazoletreatment3completed
NCT02334228
Evaluation of the In SHAPE Fitness Intervention for Adults With Serious Mental IllnessNo drug interventionspreventionNot Availablecompleted
NCT00458211
Efficacy and Tolerability of Switching to Ziprasidone From Other Antipsychoticstreatment4completed
NCT02665611
Remote Monitoring and Support for Patients With Schizophrenia, Schizoaffective or Bipolar Disorder on AdherenceNo drug interventionstreatmentNot Availableunknown_status
NCT00650611
A Study of the Safety and Tolerability of Oral Ziprasidone in Children and Teens With Psychotic Disorderstreatment2completed
NCT03576911
A Randomised Controlled Trial of Coenzyme Q10 in Patients With Schizophrenia and Schizoaffective DisorderNo drug interventionstreatmentNot Availableunknown_status
NCT03409393
Feasibility and Relevance of High-Intensity Functional Training in Patients With First-Episode PsychosisNo drug interventionssupportive_careNot Availablecompleted
NCT01992393
Targeted Self-Management for Epilepsy and Serious Mental Illness (TIME)No drug interventionssupportive_careNot Availablecompleted
NCT02137993
Efficacy and Safety of A-prexa Compared to Zyprexa in Patients With Schizophreniatreatment4completed
NCT00539071
High Dose Risperidone Consta for Patients With Schizophrenia With Poor Response to Risperidonetreatment4completed
NCT01242371
Double-Blind Trial of a Probiotic Supplement to Reduce the Symptoms of SchizophreniaNo drug interventionstreatmentNot Availablecompleted
NCT00178971
Serotonin 1A Agonists and Cognition in Schizophreniatreatment3completed
NCT01394471
Oxytocin Treatment of Social Cognitive and Functional Deficits in Schizophreniatreatment1completed
NCT00423878
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disordertreatment4completed
NCT02091388
Bioavailability of LY03004 and Risperdal® Consta®treatment1completed
NCT00297388
A Study of How Long it Takes a Patient to Relapse After Switching From an Oral Antipsychotic to One of Two Doses of Long-acting Risperidone Injections in Patients With Schizophrenia or Schizoaffective Disordertreatment3completed
NCT05204407
Luteolin for the Treatment of People With SchizophreniaNo drug interventionstreatmentNot Availablerecruiting
NCT00057707
Effects of Modafinil on Brain Function in Patients With Schizophreniaother1completed
NCT00222807
Schizophrenia, Antipsychotic Treatment and the Risk for Diabetes MellitusNo drug interventionsNot AvailableNot Availablecompleted
NCT01409109
Database Registry for Neural Network Biomarkers in PsychosisNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT00683709
Specialized Clozapine Clinic for Bipolar and Schizoaffective DisorderNo drug interventionsNot AvailableNot Availablecompleted
NCT00156715
Efficacy of Quetiapine in the Treatment of Patients With Schizophrenia and a Comorbid Substance Use Disorderother4completed
NCT00406315
Study Evaluating The Safety, Tolerability, And Efficacy Of Switching From Quetiapine To Ziprasidonetreatment4completed
NCT00156637
A Study of Strategies to Improve Schizophrenia TreatmentNo drug interventionsNot AvailableNot Availablecompleted
NCT02188732
Self-Management Training and Automated Telehealth to Improve SMI Health OutcomesNo drug interventionssupportive_careNot Availablecompleted
NCT02949232
Prednisolone Addition for Patients With Recent-onset Psychotic DisorderNo drug interventionstreatment4terminated
NCT00178932
Improving Outcome in Schizophrenia Through Identification of Genetic Risk FactorsNo drug interventionsdiagnosticNot Availablerecruiting
NCT02234752
Galantamine and Memantine Combination for Cognitive Impairments in SchizophreniaNo drug interventionstreatment2terminated
NCT00169052
Health Care Management and Rehabilitation Skills Training for Treating Serious Mental Illness in Older PeopleNo drug interventionstreatmentNot Availablecompleted
NCT05023252
Mobile Self-TrackingNo drug interventionshealth_services_researchNot Availablerecruiting
NCT01969500
Development of a Mobile System for Self-management of Schizophrenia (SOS)No drug interventionstreatmentNot Availablecompleted
NCT03701100
The Effects of Bimodal tDCS on Illness Severity, Insight, Functional Outcomes, Neurocognition and HRV in SchizophreniaNo drug interventionstreatmentNot Availablecompleted
NCT00688259
Cognitive-Behavioral Therapy in Veterans With SchizophreniaNo drug interventionstreatmentNot Availablecompleted
NCT00246259
A Trial Comparing Risperidone Long-Acting Injection With Oral Antipsychotic in the Treatment of Early PsychosisNo drug interventionstreatment4completed
NCT01420575
Decision Aid to Facilitate Shared Decision Making During Treatment in SchizophreniaNo drug interventionstreatmentNot Availableterminated
NCT00749970
Validity of the Spanish Version of Subjective Well-being Under Neuroleptics Scale (SWN-K) in Patients With SchizophreniaNo drug interventionsNot AvailableNot Availablecompleted
NCT00159770
Effect And Safety Of Ziprasidone Compared To Other Atypical Antipsychotic Drug In Schizophrenic PatientsNo drug interventionstreatment3completed
NCT00512070
Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With OlanzapineNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT00206570
Clinical Estradiol Trial in Women With SchizophreniaNo drug interventionstreatment2completed
NCT05660070
Context-Aware Mobile Intervention for Social Recovery in Serious Mental IllnessNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT05105542
M1 Schizophrenia PET StudyNo drug interventionsdiagnostic2completed
NCT01175642
Cognitive Remediation and Functional Skills Training in SchizophreniaNo drug interventionstreatment0completed
NCT02978599
Clinical Trial of AVL-3288 in Schizophrenia PatientsNo drug interventionstreatment1completed
NCT00357006
A Definitive Estrogen Patch Study (ADEPT)No drug interventionstreatment2completed
NCT00190749
Safety Study of Olanzapine and a Comparator in Patients With Schizophrenia and Schizoaffective DisorderNo drug interventionstreatment4completed
NCT00514449
Systematic Evaluation of Antiviral Medication in SchizophreniaNo drug interventionstreatment2completed
NCT00492349
Varenicline Adjunctive Treatment in SchizophreniaNo drug interventionstreatment4completed
NCT02819349
Texting for Relapse PreventionNo drug interventionspreventionNot Availablecompleted
NCT00791349
A Study of QT and QTc Intervals in Patients Administered Immediate Release PaliperidoneNo drug interventionstreatment1completed
NCT03061136
Clonazepam Effects on Brain Oscillations and Cognition in SchizophreniaNo drug interventionstreatment4withdrawn
NCT02582736
Antipsychotics and Risk of Hyperglycemic EmergenciesNo drug interventionsNot AvailableNot Availablecompleted
NCT00817336
Biomarkers in SchizophreniaNo drug interventionstreatment2completed
NCT02360813
Cognitive Remediation Therapy Within a Secure Forensic SettingNo drug interventionstreatmentNot Availablecompleted
NCT01878513
Prospective Cytochrome P450 Genotyping and Clinical Outcomes in Patients With PsychosisNo drug interventionstreatmentNot Availablecompleted
NCT01992913
Building Employment Skills Through Therapy for VeteransNo drug interventionstreatmentNot Availablecompleted
NCT00522613
Recovery Group PilotNo drug interventionssupportive_careNot Availablecompleted
NCT02576613
Modified Psychodynamic Psychotherapy for Patients With SchizophreniaNo drug interventionstreatmentNot Availablecompleted
NCT00591318
A Placebo-controlled Efficacy Study of IV Ceftriaxone for Refractory PsychosisNo drug interventionstreatment1 / 2terminated
NCT00714818
Impact of Genetic Counseling for Female First Degree Relatives of Individuals With Mental IllnessNo drug interventionsNot Available3completed
NCT00547118
The Effects of Rimonabant, on Weight and Metabolic Risk FactorsNo drug interventionstreatment2terminated
NCT00857818
Trial Comparing the Effects of Aripiprazole With Those of Standard of Care on Non-HDL Cholesterol in Patients With Schizophrenia or Bipolar I Disorder Who Have Metabolic SyndromeNo drug interventionstreatment3terminated
NCT00406718
Improving Adherence to Oral Antipsychotic Medications in People With SchizophreniaNo drug interventionstreatmentNot Availablecompleted
NCT00139919
Progressively Decreasing Titration Schedules of Bifeprunox in Subjects With Schizophrenia or Bipolar DisorderNo drug interventionstreatment2completed
NCT02074319
RCT of Methotrexate Added to Treatment As Usual in SchizophreniaNo drug interventionstreatment1completed
NCT03404219
Motivation and Skills Support (MASS)No drug interventionshealth_services_researchNot Availablecompleted
NCT01952041
A New Paradigm for Illness Monitoring and Relapse Prevention in SchizophreniaNo drug interventionstreatmentNot Availablecompleted
NCT03510741
Sodium Benzoate and/or N-Acetylcysteine Added to TAU in Patients With Early Schizophrenia Spectrum Disorder.No drug interventionsother2completed
NCT02433717
A Pharmacokinetic Study of Paliperidone ERNo drug interventionstreatment4unknown_status
NCT02453217
The Potential Efficacy of the Chinese Health Improvement Profile- A Pilot Clustered Randomised Controlled TrialNo drug interventionshealth_services_researchNot Availablecompleted
NCT00399334
PROFILe3: Epidemiologic Survey in Patients With Schizophrenia or Schizoaffective DisordersNo drug interventionsNot AvailableNot Availablecompleted
NCT03848234
Estradiol Patch as add-on to Antipsychotics in Patients With Schizophrenia, Schizoaffective or Schizophreniform DisorderNo drug interventionstreatment3completed
NCT04580134
CLOZAPINE Response in Biotype-1No drug interventionstreatment4recruiting
NCT00688324
Biomarker Study of Acamprosate in SchizophreniaNo drug interventionstreatment4completed
NCT00095524
Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective DisorderNo drug interventionstreatment3completed
NCT05338424
Exercise Target Brain Oscillations in PsychosisNo drug interventionsNot AvailableNot Availablewithdrawn
NCT01780116
Effectiveness of Adherence Therapy for SchizophreniaNo drug interventionshealth_services_research1 / 2completed
NCT03179696
Mobile-Assisted Cognitive Behavior Therapy for Negative Symptoms in SchizophreniaNo drug interventionstreatmentNot Availablecompleted
NCT01339858
The Effect of N-Acetyl Cysteine on Cortical Erosion in Early Stage SchizophreniaNo drug interventionstreatment4completed
NCT06002958
Horyzons: Implementation and Integration in Clinical PracticeNo drug interventionstreatmentNot Availablerecruiting
NCT00734435
Olanzapine Given in Combination With Zonisamide SR to Prevent Weight Gain in Schizophrenic SubjectsNo drug interventionstreatment2terminated
NCT02221635
Efficacy of Repetitive Transcranial Magnetic Stimulation in the Prevention of Relapse of SchizoaffectiveNo drug interventionsNot AvailableNot Availableunknown_status
NCT00566735
The Use of Galantamine HBr (Reminyl) in Electroconvulsive Therapy: Impact on Mood and Cognitive FunctioningNo drug interventionstreatment3completed
NCT00222235
Adjunctive Treatment for Decreasing Symptoms of SchizophreniaNo drug interventionstreatment2 / 3completed
NCT05140135
Effectiveness and Mechanisms of Recovery Oriented Cognitive TherapyNo drug interventionstreatmentNot Availablewithdrawn
NCT01556763
Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With SchizophreniaNo drug interventionstreatment1completed
NCT02529163
Evaluating the Efficacy of a Late-Life Schizophrenia Integrated Care Pathway to Treat Acute Psychotic SymptomsNo drug interventionstreatmentNot Availableunknown_status
NCT00330863
Preventing Relapse in Schizophrenia: Oral Antipsychotics Compared To Injectables: Evaluating EfficacyNo drug interventionstreatment4completed
NCT01490086
RP5063 in Subjects With Schizophrenia or Schizoaffective DisorderNo drug interventionstreatment2completed
NCT01196286
Multifamily Psychoeducation and Cognitive Remediation for Recent-Onset PsychosisNo drug interventionstreatmentNot Availablecompleted
NCT01578486
Salsalate as an Adjunctive Treatment for Patients With SchizophreniaNo drug interventionstreatment4completed
NCT01831986
Pregnenolone and L-theanine Augmentation in the Treatment for Schizophrenia and Schizoaffective DisordersNo drug interventionstreatmentNot Availableunknown_status
NCT06159322
Characterizing Response to Antipsychotics in SchizophreniaNo drug interventionsNot AvailableNot Availablerecruiting
NCT00791622
A Study of QT and QTc Intervals in Patients Administered Extended Release Paliperidone or QuetiapineNo drug interventionstreatment1completed
NCT00864825
Allopurinol in Schizophrenia: A Randomized Trial Administering Allopurinol vs Placebo as add-on Antipsychotics in Patients With SchizophreniaNo drug interventionstreatment4completed
NCT00990925
Lifestyle Modification for Weight Loss in SchizophreniaNo drug interventionstreatmentNot Availablecompleted
NCT00237848
D-Serine for Enhancing Cognitive Retraining for the Treatment of SchizophreniaNo drug interventionstreatment3completed
NCT04497857
Academic-Community EPINET (AC-EPINET)No drug interventionshealth_services_researchNot Availablerecruiting
NCT01519557
Pharmacologic and Clinical Testing of a D1 Agonist for Cognitive Enhancement in Neuropsychiatric DisordersNo drug interventionstreatment0completed
NCT03261557
Cognitive Behavioral Social Skills Training in Early Onset PsychosisNo drug interventionstreatmentNot Availableunknown_status
NCT00206557
The Use of Selective Estrogen Receptor Modulators in the Treatment of Schizophrenia- a Pilot StudyNo drug interventionstreatment2completed
NCT02411526
Safety and PK Trial With Injectable ZX003 (Risperidone-SABER®) Compared to Risperdal® Consta® in Stable SchizophreniaNo drug interventionstreatment1completed
NCT06005766
The Efficacy of Metacognitive Skills Training in the Context of Forensic Psychiatric CareNo drug interventionstreatmentNot Availablerecruiting
NCT02421965
Comparing Mobile Health (mHealth) and Clinic-Based Self-Management Interventions for Serious Mental IllnessNo drug interventionstreatmentNot Availablecompleted
NCT01706965
Kuvan in People With Schizophrenia and Schizoaffective DisorderNo drug interventionstreatment1 / 2completed
NCT00088465
Open-Label Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective DisorderNo drug interventionstreatment3completed
NCT00007774
To Determine if Olanzapine is More Cost Effective Than Haloperidol for the Treatment of SchizophreniaNo drug interventionsNot Available4completed
NCT00119574
Evaluating a Collaborative Care Model for the Treatment of Schizophrenia (EQUIP)No drug interventionstreatmentNot Availablecompleted
NCT01036282
Cognitive Skills Training Using Computer for Patients With Severe Mental IllnessNo drug interventionstreatment4completed
NCT00179231
Olanzapine Versus Clozapine in Treatment Refractory SchizophreniaNo drug interventionstreatmentNot Availablecompleted
NCT00588731
Cannabidiol Treatment of Cognitive Dysfunction in SchizophreniaNo drug interventionstreatment2completed
NCT00395031
Effect of Ziprasidone on Glucose & Plasma Lipids in Diabetes (II) and Schizophrenia or Schizoaffective DisorderNo drug interventionstreatment2 / 3completed
NCT04144231
Cognitive Behavioral Therapy for Insomnia (CBT-I) in Schizophrenia(SLEEPINS)No drug interventionstreatmentNot Availablerecruiting
NCT01624831
Social Cognition in Longstanding PsychosisNo drug interventionsNot AvailableNot Availableterminated
NCT02462473
A Study to Assess the Clinical Utility of Antipsychotic Medication Levels in Plasma as Determined by Liquid Chromatography-Tandem Mass SpectrometryNo drug interventionstreatment2terminated
NCT00412373
Evaluation of Effectiveness and Safety of Flexible-dose Paliperidone Extended Release in Patients With Schizoaffective Disorder.No drug interventionstreatment3completed
NCT00349973
Clinical Trial of Dipyridamole in SchizophreniaNo drug interventionstreatmentNot Availablecompleted
NCT05974527
Pilot Study 1: Efficacy and Safety of Sublingual Dexmedetomidine (BXCL501) for the Treatment of Agitation in the Emergency DepartmentNo drug interventionstreatment4not_yet_recruiting
NCT05457127
Obstructive Sleep Apnea Treatment in Serious Mental IllnessNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT04551027
Assessing the Effect of Compensatory Cognitive Intervention Among People With Severe Mental IllnessNo drug interventionstreatmentNot Availableunknown_status
NCT01259427
Reducing Internalized Stigma in People With Serious Mental IllnessNo drug interventionstreatment2completed
NCT01888627
Integrated Care in Psychotic Disorders With Severe Mental IllnessNo drug interventionstreatmentNot Availablerecruiting
NCT00833976
Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated HypertriglyceridemiaNo drug interventionstreatment4completed
NCT01963676
Transcranial Current Stimulation as a Treatment for Auditory Hallucinations in SchizophreniaNo drug interventionstreatmentNot Availablecompleted
NCT03919760
Early Psychosis Intervention - Spreading Evidence-based TreatmentNo drug interventionsNot AvailableNot Availableunknown_status
NCT03390491
OnTrack>An Online Role-Playing Game for Young People With First Episode PsychosisNo drug interventionsotherNot Availablecompleted
NCT01216891
Multi-disciplinary Treatment for Patients Experiencing First Episode of PsychosisNo drug interventionstreatmentNot Availablecompleted
NCT00313391
Risperdal Consta and Health Care Utilization in Patients With SchizophreniaNo drug interventionsNot Available4completed
NCT00337662
Efficacy Study of Early Onset of Antipsychotic Drug Action in SchizophreniaNo drug interventionstreatment4completed
NCT03829280
Cognitive Adaption Training-Effectiveness in Real-world Settings and Mechanism of Action (CAT-EM)No drug interventionstreatmentNot Availablecompleted
NCT02032680
Comparison of E-health vs. In-person Multi-Family Group (MFG)No drug interventionstreatmentNot Availablecompleted
NCT00434980
Family-Directed Cognitive Adaptation Program for Individuals With SchizophreniaNo drug interventionstreatmentNot Availablecompleted
NCT03240380
Joint Crisis Plans or Crisis Cards for People With Severe Mental Disorders to Reduce Coercion in Psychiatric Care.No drug interventionstreatmentNot Availableunknown_status
NCT00793780
Pilot Trial of Naltrexone for Obesity in Women With SchizophreniaNo drug interventionstreatmentNot Availablecompleted
NCT00018629
Cognitive - Behavioral TherapyNo drug interventionsNot Available2completed
NCT02664129
Video as a Tool to Improve Insight in SchizophreniaNo drug interventionstreatmentNot Availablecompleted
NCT01602029
Randomized Double Blind Placebo Control Study in Patients With SchizophreniaNo drug interventionstreatment2completed
NCT00515489
Study on the Safety and Effectiveness of Risperidone Treatment of Acute Psychotic PatientsNo drug interventionsNot AvailableNot Availableterminated
NCT01929889
Assessing the Effects of Fanapt® on Social Cognition in SchizophreniaNo drug interventionstreatment4terminated
NCT00401089
Efficacy Study of Panax Ginseng to Boost Antipsychotics Effects in SchizophreniaNo drug interventionstreatment1 / 2completed
NCT01431092
Melatonin Versus Placebo for Benzodiazepine Discontinuation in Patients With SchizophreniaNo drug interventionstreatment4completed
NCT04324944
Adapting and Examining Collaborative Decision Skills Training Among Veterans With Serious Mental IllnessNo drug interventionstreatmentNot Availablerecruiting
NCT02364544
Improving Care and Reducing Cost StudyNo drug interventionstreatmentNot Availablecompleted
NCT00288340
Quantifying Abnormalities in Cortical Activation Associated With Auditory Hallucinations Using Functional Magnetic Resonance ImagingNo drug interventionstreatmentNot Availablecompleted
NCT00094640
Pharmacokinetic Characterization of Intramuscular Olanzapine DepotNo drug interventionstreatment1completed
NCT00458367
RiSPECT: Risperdal Safety Protocol Evaluation Consta Treatment, a Post Authorization Safety Survey to Obtain Information on the Safety and Efficacy of Risperidone When Used in Routine Clinical PracticeNo drug interventionsNot AvailableNot Availablecompleted
NCT01324167
Effects of Gene Polymorphisms on Metabolic Features in Clozapine-treated Patients With SchizophreniaNo drug interventionsNot AvailableNot Availableunknown_status
NCT03062267
Effectiveness of a Mobile Texting Intervention for People With Serious Mental IllnessNo drug interventionstreatmentNot Availablecompleted
NCT06558201
Open Label Extension Study of NCT06221852No drug interventionstreatmentNot Availableenrolling_by_invitation
NCT02354001
Selective Estrogen Receptor Modulators for Women of Child-bearing Age With SchizophreniaNo drug interventionstreatment4completed
NCT01384604
Neurophysiological Studies in Schizophrenia and Psychiatric DisordersNo drug interventionsNot AvailableNot Availablecompleted
NCT00713804
Impact of Genetic Counseling for Individuals With Mental IllnessNo drug interventionsNot Available3completed
NCT00362804
Tetrabenazine for Partial RespondersNo drug interventionstreatmentNot Availablecompleted
NCT05030272
Comparing Two Behavioral Approaches to Quitting Smoking in Mental Health SettingsNo drug interventionstreatmentNot Availablerecruiting
NCT01487668
Life Goals Collaborative Care to Improve Health Outcomes in Mental DisordersNo drug interventionshealth_services_researchNot Availablecompleted
NCT01786369
Adherence in Patients Admitted to a Psychiatric Unit for Acute Psychosis: an Analysis of Serum Levels of Antipsychotics.No drug interventionsNot AvailableNot Availablecompleted
NCT00661869
Outcome Evaluation of Solutions for Wellness and Team Solutions Program in Patients With Severe Mental IllnessNo drug interventionssupportive_careNot Availablecompleted
NCT02186769
An Randomized Open-Label PK Study of LY03004 Compared to Risperdal® Consta® in Stable Patients With Schizophrenia or Schizoaffective DisorderNo drug interventionstreatment1completed
NCT03076346
Neural Biomarkers of Clozapine ResponseNo drug interventionsNot AvailableNot Availablecompleted
NCT01752712
Oxytocin and CBSST for People With SchizophreniaNo drug interventionstreatmentNot Availablecompleted
NCT05658510
Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III)No drug interventionstreatment3active_not_recruiting
NCT04870710
Feasibility Electrical Stimulation Study for Visual HallucinationsNo drug interventionstreatmentNot Availablecompleted
NCT05527210
Prebiotic Treatment in People With SchizophreniaNo drug interventionsotherNot Availablerecruiting
NCT00796081
A Safety and Pharmacokinetic Study of ER OROS Paliperidone in Pediatric Patients With Schizophrenia, Schizoaffective Disorder, or Schizophreniform DisorderNo drug interventionstreatment1completed
NCT04251195
Verbal Memory Training Using Virtual Reality in SchizophreniaNo drug interventionstreatmentNot Availablecompleted
NCT01075295
Prevention of Weight Gain in Early PsychosesNo drug interventionspreventionNot Availablecompleted
NCT00617214
Schizophrenic Patients Taking Part in Integrated Care ProgramNo drug interventionsNot AvailableNot Availableterminated
NCT00498550
Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-UsualNo drug interventionstreatment4completed
NCT00520650
Health Evaluation of Abilify Long-term TherapyNo drug interventionstreatment4completed
NCT00466323
The Effectiveness of FMPO in Improving the Quality of Care for Persons With Severe Mental Illness.No drug interventionstreatmentNot Availablecompleted
NCT00515723
Glucose and Lipid Metabolism on Antipsychotic MedicationNo drug interventionstreatmentNot Availablecompleted
NCT02476708
A Pilot Trial of Curcumin Effects on Cognition in SchizophreniaNo drug interventionstreatmentNot Availableterminated
NCT06562608
Anticholinergic Deprescription in SchizophreniaNo drug interventionstreatment4not_yet_recruiting
NCT01596608
Magnetic Seizure Therapy (MST) for Treatment Resistant Depression, Schizophrenia, and Obsessive Compulsive DisorderNo drug interventionstreatmentNot Availablecompleted
NCT00914238
Extended Specialized Assertive Intervention for First Episode PsychosisNo drug interventionstreatmentNot Availablecompleted